Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1677-1682

  Björnsson, Einar ^a,b   Angulo, Paul ^a  

^a MAYO CLINIC   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; ENTERITIS; FEMALE; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGITIS, SCLEROSING; CROHN DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; PROGNOSIS; RISK FACTORS;

EID: 34547635802     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01220.x     Document Type: Article

References (52)

1. Wiesner RH, Porayko MK, Dickson ER, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992 16 : 1290 9.
2. Narumi S, Roberts JP, Emond JC, et al. Liver transplantation for sclerosing cholangitis. Hepatology 1995 22 : 451 7.
3. Brandsaeter B, Broome U, Isoniemi H, et al. Liver transplantation for primary sclerosing cholangitis in the Nordic countries: Outcome after acceptance to the waiting list. Liver Transpl 2003 9 : 961 9.
4. Cullen SN, Chapman RW. The medical management of primary sclerosing cholangitis. Semin Liver Dis 2006 26 : 52 61.
5. Chapman RW, Arborgh BM, Rhodes JM, et al. Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology. Gut 1980 21 : 1870 7.
6. Mir-Madjlessi SH, Farmer RG, Sivak MV Jr. Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: Report of six cases and review of the literature. Dig Dis Sci 1987 32 : 145 54.
7. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: A long-term follow-up study. Scand J Gastroenterol 1987 22 : 655 64.
8. Rosen CB, Nagorney DM, Wiesner RH, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991 213 : 21 5.
9. Farrant JM, Hayllar KM, Wilkinson ML, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991 100 : 1710 7.
10. Broomé U, Olsson R, Lööf L, et al. Natural history and prognostic factors in 305 patients with primary sclerosing cholangitis. Gut 1996 38 : 610 5.
11. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 2000 31 : 7 11.
12. Burak K, Angulo P, Pasha TM, et al. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004 99 : 523 6.
13. Abu-Elmagd KM, Selby R, Iwatsuki S, et al. Cholangiocarcinoma and sclerosing cholangitis: Clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993 25 : 1124 5.
14. Knechtle SJ, D'Alessandro AM, Harms BA, et al. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995 118 : 615 9.
15. Stieber AC, Marino IR, Iwatsuki S, et al. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989 74 : 1 3.
16. Boberg KM, Bergquist A, Mitchell S, et al. Cholangiocarcinoma in primary sclerosing cholangitis: Risk factors and clinical presentation. Scand J Gastroenterol 2002 37 : 1205 11.
17. Ahrendt SA, Pitt HA, Nakeeb A, et al. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg 1999 3 : 357 67.
18. Kaya M, de Groen PC, Angulo P, et al. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: The Mayo Clinic experience. Am J Gastroenterol 2001 96 : 1164 9.
19. Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999 10 (Suppl 4 308 11.
20. Bergquist A, Broome U. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001 15 : 643 56.
21. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma-a study of 51 cases from a low-endemicity area. Acta Oncol 1998 37 : 77 83.
22. Björnsson E, Gustafsson J, Borkman J, et al. What happens to patients with obstructive jaundice? Gastroenterology 2006 130 (Suppl 2 A4Z9.
23. El-Shabrawi M, Wilkinson ML, Portmann B, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987 92 : 1226 35.
24. Debray D, Pariente D, Urvoas E, et al. Sclerosing cholangitis in children. J Pediatr 1994 124 : 49 56.
25. Wilschanski M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995 22 : 1415 22.
26. Floreani A, Zancan L, Melis A, et al. Primary sclerosing cholangitis (PSC): Clinical, laboratory and survival analysis in children and adults. Liver 1999 19 : 228 33.
27. Feldstein AE, Perrault J, El-Youssif M, et al. Primary sclerosing cholangitis in children: A long-term follow-up study. Hepatology 2003 38 : 210 7.
28. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study. Hepatology 2001 33 : 544 53.
29. MacCarty RL, LaRusso NF, Wiesner RH, et al. Primary sclerosing cholangitis; findings on cholangiography and pancreatography. Radiology 1983 149 : 39 44.
30. Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991 11 : 31 9.
31. Ueda M, Nakamura T, Tohyama T, et al. Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis. J Hepatobiliary Pancreat Surg 2003 10 : 245 9.
32. Lipsett PA, Pitt HA, Colombani PM, et al. Choledochal cyst disease. A changing pattern of presentation. Ann Surg 1994 220 : 644 52.
33. Voyles CR, Smadja C, Shands WC, et al. Carcinoma in choledochal cysts. Age-related incidence. Arch Surg 1983 118 : 986 8.
34. Barros JL, Polo JR, Sanabia J, et al. Congenital cystic dilatation of the intrahepatic bile ducts (Caroli's disease): Report of a case and review of the literature. Surgery 1979 85 : 589 92.
35. Dayton MT, Longmire WP Jr., Tompkins RK. Caroli's disease: A premalignant condition? Am J Surg 1983 145 : 41 8.
36. Taylor AC, Palmer KR. Caroli's disease. Eur J Gastroenterol Hepatol 1998 10 : 105 8.
37. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003 38 : 560 6.
38. Reynolds M. Pediatric liver tumors. Cancer Treat Res 2001 109 : 299 312.
39. Klein WM, Molmenti EP, Colombani PM, et al. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol 2005 124 : 512 8.
40. Björnsson E, Boberg KM, Cullen S, et al. Patients with small duct primary sclerosing cholangitis have a favourable long-term prognosis. Gut 2002 51 : 731 5.
41. Farges O, Malassagne B, Sebagh M, et al. Primary sclerosing cholangitis: Liver transplantation or biliary surgery. Surgery 1995 117 : 146 55.
42. Wee A, Ludwig J, Coffey RJ Jr., et al. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol 1985 16 : 719 26.
43. Bergquist A, Glaumann H, Persson B, et al. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study. Hepatology 1998 27 : 311 6.
44. Hultcrantz R, Olsson R, Danielsson A, et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol 1999 30 : 669 73.
45. Nashan B, Schlitt HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation. Hepatology 1996 23 : 1105 11.
46. Helzberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987 92 : 1869 75.
47. Angulo P, Maor-Kendler Y, Lindor KD. Small-duct primary sclerosing cholangitis: Prevalence and natural history. Hepatology 2002 35 : 1494 500.
48. Broome U, Glaumann H, Lindstom E, et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002 36 : 586 9.
49. Nichols JC, Gores GJ, LaRusso NF, et al. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993 68 : 874 9.
50. Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995 108 : 865 9.
51. Björnsson E, Kilander A, Olsson R. CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver 1999 19 : 501 8.
52. Levy C, Lymp J, Angulo P, et al. The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis. Dig Dis Sci 2005 50 : 1734 40.